According to Mersana Therapeutics's latest financial reports the company's current revenue (TTM ) is C$50.27 Million. In 2023 the company made a revenue of C$48.88 Million an increase over the revenue in the year 2022 that were of C$36.06 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 (TTM) | C$46.87 M | -4.12% |
2023 | C$48.88 M | 35.52% |
2022 | C$36.06 M | 64222.53% |
2021 | C$0.05 M | -94.7% |
2020 | C$1.05 M | -98.08% |
2019 | C$55.01 M | 281.19% |
2018 | C$14.43 M | -34.57% |
2017 | C$22.05 M | -34.79% |
2016 | C$33.82 M |